Sleep in Duchenne Muscular Dystrophy

Breathing in Duchenne muscular dystrophy gets harder at night before it gets harder during the day. That makes sleep the earliest place to see respiratory trouble, and the earliest place to act on it. This post explains why sleep changes first, what the right surveillance looks like, and what the common pitfalls are.

Why night comes first

During sleep, especially REM sleep, most respiratory muscles relax. The accessory muscles of breathing that compensate for diaphragm weakness during the day are offline. In DMD, where the diaphragm is already working harder than normal, that loss of accessory support produces measurable hypoventilation at night well before daytime symptoms appear.

The same patient can have a normal-looking daytime vital capacity and still spend hours each night with elevated carbon dioxide. Daytime tests cannot detect this. That is why sleep deserves its own surveillance track.

For background, see respiratory care in DMD.

What to watch for

The clinical signs of sleep-disordered breathing in DMD can be subtle: morning headaches, daytime sleepiness, irritability, poor concentration, restless or fragmented sleep, frequent waking, and unexplained weight loss. Some patients have no symptoms at all and are picked up only on a routine sleep study.

Family observations matter. Snoring, pauses in breathing, gasping, sweating during sleep, and unusual sleep positions are worth raising at clinic visits.

Polysomnography is the standard

A formal in-lab polysomnogram, sometimes called a sleep study, is the standard diagnostic tool. It records sleep stages, breathing, oxygen saturation, end-tidal or transcutaneous carbon dioxide, heart rate, and limb movements over a full night.

The American Thoracic Society consensus statement on respiratory care in DMD recommends regular sleep history review at every visit and annual formal sleep evaluation once a patient becomes non-ambulatory, or sooner if clinically indicated. (Sleep-Disordered Breathing in DMD, an Assessment of the Literature, PMC)

What overnight oximetry misses

A common shortcut, especially in centers without easy access to full polysomnography, is overnight pulse oximetry. It is useful, but it has a real blind spot.

Oximetry detects oxygen desaturation. It does not detect carbon dioxide retention. In DMD, nocturnal hypoventilation often presents with elevated CO2 well before significant desaturation appears, because supplemental motivation to breathe is being lost rather than oxygen exchange failing. A normal overnight oximetry result in a DMD patient with symptoms does not rule out a problem; CO2 monitoring (end-tidal or transcutaneous) is the more sensitive measure. (Polysomnography assessment of sleep-related breathing in DMD, PMC)

Disease-specific criteria

Standard adult or pediatric sleep apnea scoring is calibrated to populations with predominantly obstructive disease. DMD has a mix of obstructive events and central hypoventilation, with respiratory muscle weakness driving much of the picture.

DMD-specific criteria for interpreting polysomnography in this population have been described in the literature, and they identify abnormalities that general criteria miss. Reading the study with neuromuscular criteria in mind is part of why a center experienced with neuromuscular disease matters. (Characterization of sleep-disordered breathing in DMD, AASM vs disease-specific criteria, PMC)

When ventilation starts

When nocturnal hypoventilation is documented, bilevel positive airway pressure (BiPAP) is the standard first step. It is delivered through a nasal or full-face mask, only at night, and supports each breath to correct nighttime carbon dioxide retention.

This is usually reversible. It is also usually the start of a long, gradual conversation about ventilatory support that may eventually extend into the day for some patients.

CPAP, used for routine obstructive sleep apnea, is generally not the right tool for DMD-related hypoventilation. The mechanism is different.

For background, see respiratory care in DMD.

What families can ask

A short list at clinic visits:

• When is the next sleep evaluation scheduled, and what will it measure?
• Will the study include CO2 monitoring, or only oximetry?
• Does the sleep center interpret polysomnography with neuromuscular criteria?
• What signs should we watch for between visits?
• Who do we contact if sleep symptoms appear sooner?

Asking shifts surveillance from generic to fitted.

What is still uncertain

Optimal screening intervals, the role of home-based studies versus in-lab polysomnography, and the impact of newer disease-modifying therapies on the timing of sleep-disordered breathing all continue to be studied.

The reasonable framing is that sleep in DMD is a sentinel system: it shows the disease’s effects first, and acting early protects daytime function and quality of life downstream. The decisions belong to the care team.

For related reading, see respiratory care in DMD, heart care in DMD, and DMD standards of care.

Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.